<DOC>
	<DOCNO>NCT01421459</DOCNO>
	<brief_summary>The main purpose study compare effectiveness safety LY2963016 versus Lantus control blood sugar level combination two oral diabetes medication .</brief_summary>
	<brief_title>A Study Adults With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Have Type 2 Diabetes Mellitus base disease diagnostic criterion World Health Organization ( WHO ) classification Have take least 2 type oral diabetes medication least 12 week prior enter study Have Hemoglobin A1c value great equal 7.0 percent less equal 11.0 percent insulin naive If previously Lantus , Hemoglobin A1c must less equal 11.0 percent Have body mass index less equal 45 kilogram per meter square ( kg/m^2 ) Have significant liver , cardiac gastrointestinal disease Have active cancer cancer within past 5 year ( exception basal cell carcinoma carcinoma situ ) Have excessive resistance insulin hypersensitivity Lantus Have one episode severe low blood sugar ( define need someone else help low blood sugar ) within 6 month enter study Have take insulin Lantus within past 30 day Taking diabetes medicine allow study approve take insulin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Type 2 Diabetes</keyword>
</DOC>